My Favorite Psychedelic Stocks: Part 1
Our resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race.
Day: March 10, 2022
Psychedelic Researchers Doubt Microdosing in New York Times
After a disappointing microdosing study, Dr. Michiel van Elk says the trend is “just not that interesting.”
End of content
End of content